Closed Solicitation · DEPT OF DEFENSE
AI Summary
The Defense Logistics Agency requires the supply of Midazolam Injection CIV, 10mg/0.7mL Auto-injector under a firm-fixed price contract. The solicitation will be issued around October 2025, and interested parties must have FDA approval for the product prior to the closing date. Proposals from responsible sources will be considered.
Solicitation: SPE2DP-25-R-0007
Item: Midazolam Injection CIV, 10mg/0.7mL Auto-injector
NSN: 6505-31-019-0519
Description:
The Defense Logistics Agency Troop Support has a requirement for the supply of Midazolam Injection CIV, 10mg/0.7mL Auto-injector. The Midazolam Auto-injector shall be made in accordance with MPID Number 1 dated January 31, 2025, which is attached to this notice.
The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1), only one responsible source.
The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of a base year and four (4) one-year options. The minimum quantity for each term is 135,000 each. The annual estimated quantity for each term is 234,240 each. The maximum quantity for each term is 732,480 each.
Inspection/Acceptance at Destination
FOB Destination
Delivery Destination:
DODDAC: SW3329
DLA Distribution Susquehanna PA
East U Avenue
Bldg. 89, Door 6
New Cumberland, PA 17070-500
Production Lead Time is 180 days after issuance date of the delivery order (DD1155).
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell Midazolam Injection CIV, 10mg/0.7mL Auto-injector prior to solicitation closing date.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-25-R-0007 is expected to be issued in or around October 2025.
MIDAZOLAM INJECTION CIV, 10MG/0.7ML AUTO-INJECTOR is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.